undefined

S5-07 PRELIMINARY EFFICACY AND SAFETY OF PEMBROLIZUMAB (MK-3475) IN PATIENTS WITH PD-L1-POSITIVE, ESTROGEN RECEPTOR-POSITIVE (ER+)/HER2-NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028Speaker: Hope S Rugo

Slide 1 / 20

Slide 2 / 20

Page 1

undefined

S5-07 PRELIMINARY EFFICACY AND SAFETY OF PEMBROLIZUMAB (MK-3475) IN PATIENTS WITH PD-L1-POSITIVE, ESTROGEN RECEPTOR-POSITIVE (ER+)/HER2-NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028Speaker: Hope S Rugo

Slide 3 / 20

Slide 4 / 20

Page 2

undefined

S5-07 PRELIMINARY EFFICACY AND SAFETY OF PEMBROLIZUMAB (MK-3475) IN PATIENTS WITH PD-L1-POSITIVE, ESTROGEN RECEPTOR-POSITIVE (ER+)/HER2-NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028Speaker: Hope S Rugo

Slide 5 / 20

Slide 6 / 20

Page 3

undefined

S5-07 PRELIMINARY EFFICACY AND SAFETY OF PEMBROLIZUMAB (MK-3475) IN PATIENTS WITH PD-L1-POSITIVE, ESTROGEN RECEPTOR-POSITIVE (ER+)/HER2-NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028Speaker: Hope S Rugo

Slide 7 / 20

Slide 8 / 20

Page 4

undefined

S5-07 PRELIMINARY EFFICACY AND SAFETY OF PEMBROLIZUMAB (MK-3475) IN PATIENTS WITH PD-L1-POSITIVE, ESTROGEN RECEPTOR-POSITIVE (ER+)/HER2-NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028Speaker: Hope S Rugo

Slide 9 / 20

Slide 10 / 20

Page 5

undefined

S5-07 PRELIMINARY EFFICACY AND SAFETY OF PEMBROLIZUMAB (MK-3475) IN PATIENTS WITH PD-L1-POSITIVE, ESTROGEN RECEPTOR-POSITIVE (ER+)/HER2-NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028Speaker: Hope S Rugo

Slide 11 / 20

Slide 12 / 20

Page 6

undefined

S5-07 PRELIMINARY EFFICACY AND SAFETY OF PEMBROLIZUMAB (MK-3475) IN PATIENTS WITH PD-L1-POSITIVE, ESTROGEN RECEPTOR-POSITIVE (ER+)/HER2-NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028Speaker: Hope S Rugo

Slide 13 / 20

Slide 14 / 20

Page 7

undefined

S5-07 PRELIMINARY EFFICACY AND SAFETY OF PEMBROLIZUMAB (MK-3475) IN PATIENTS WITH PD-L1-POSITIVE, ESTROGEN RECEPTOR-POSITIVE (ER+)/HER2-NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028Speaker: Hope S Rugo

Slide 15 / 20

Slide 16 / 20

Page 8

undefined

S5-07 PRELIMINARY EFFICACY AND SAFETY OF PEMBROLIZUMAB (MK-3475) IN PATIENTS WITH PD-L1-POSITIVE, ESTROGEN RECEPTOR-POSITIVE (ER+)/HER2-NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028Speaker: Hope S Rugo

Slide 17 / 20

Slide 18 / 20

Page 9

undefined

S5-07 PRELIMINARY EFFICACY AND SAFETY OF PEMBROLIZUMAB (MK-3475) IN PATIENTS WITH PD-L1-POSITIVE, ESTROGEN RECEPTOR-POSITIVE (ER+)/HER2-NEGATIVE ADVANCED BREAST CANCER ENROLLED IN KEYNOTE-028Speaker: Hope S Rugo

Slide 19 / 20

Slide 20 / 20

Page 10